Kelly Education Introduces First-of-Its-Kind LEARN Standards for Substitute Teachers and Paraeducators Comprehensive Framework Developed by Ed.D. Credentialed Educators and HR Experts Sets New Benchmark for Education Workforce Quality GlobeNewswire November 17, 2025 TROY, Mich., Nov. 17, 2025 (GLOBE NEWSWIRE) — Kelly Education, the nation's leading provider of education talent and workforce solutions, today announced the […]

ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals GlobeNewswire November 17, 2025 UNIONDALE, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) reminds shareholders of record as of October 20, 2025, of the Company's upcoming Special Meeting of Stockholders, which will be held on November 24, 2025, at

Enphase Energy Expands IQ Meter Collar Approvals in the United States, including PG&E in California GlobeNewswire November 17, 2025 FREMONT, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced an expanded number of utilities

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology GlobeNewswire November 17, 2025 NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment

Algoma Steel Completes $500 Million Government Financing Transaction $400 million from the Canada Enterprise Emergency Funding Corporation (CEEFC) and $100 million from the Province of Ontario strengthening Algoma's balance sheet as the Company advances its EAF transition GlobeNewswire November 17, 2025 SAULT STE. MARIE, Ontario, Nov. 17, 2025 (GLOBE NEWSWIRE) — Algoma Steel Group Inc.

PetVivo Holdings Announces Digital Landia's Publication of Technical Whitepaper Validating AgenticPet AI Framework Under Exclusive 10-Year Licensing Agreement GlobeNewswire November 17, 2025 Comprehensive Documentation Confirms Production-Ready Architecture for PetVivo's Veterinary Platform Launching Q1 2026 MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly owned subsidiaries

Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study GlobeNewswire November 17, 2025 EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing previously reported pain reduction and opioid-free outcomes Late-stage patients showed substantial

NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts GlobeNewswire November 17, 2025 Extends cash runway into first half of 2027, beyond planned first half of 2026 proof of concept (“POC”) data readouts of SIM0505 (CDH6 ADC) and LNCB74 (B7-H4 ADC) Led by Ikarian Capital,

T-knife Therapeutics Files Clinical Trial Application for Phase 1 ATLAS Trial for TK-6302, a Supercharged PRAME-targeted T Cell Receptor Therapy GlobeNewswire November 17, 2025 — Preclinical data with TK-6302 has shown best-in-class anti-tumor efficacy, demonstrating its potential to elicit deep and durable responses in diverse solid tumor indications with high unmet need — Following CTA

Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit GlobeNewswire November 17, 2025 NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced